Ginkgo Bioworks Holdings (DNABW) EBT Margin (2020 - 2025)
Historic EBT Margin for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to 207.93%.
- Ginkgo Bioworks Holdings' EBT Margin fell 1441700.0% to 207.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 188.29%, marking a year-over-year increase of 1106500.0%. This contributed to the annual value of 241.15% for FY2024, which is 1139600.0% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its EBT Margin stood at 207.93% for Q3 2025, which was down 1441700.0% from 122.13% recorded in Q2 2025.
- Ginkgo Bioworks Holdings' 5-year EBT Margin high stood at 63.76% for Q3 2024, and its period low was 1081.31% during Q4 2021.
- In the last 5 years, Ginkgo Bioworks Holdings' EBT Margin had a median value of 245.99% in 2024 and averaged 357.98%.
- In the last 5 years, Ginkgo Bioworks Holdings' EBT Margin plummeted by -9366000bps in 2021 and then surged by 8901800bps in 2022.
- Over the past 5 years, Ginkgo Bioworks Holdings' EBT Margin (Quarter) stood at 1081.31% in 2021, then surged by 82bps to 191.13% in 2022, then plummeted by -219bps to 609.67% in 2023, then surged by 60bps to 245.99% in 2024, then rose by 15bps to 207.93% in 2025.
- Its last three reported values are 207.93% in Q3 2025, 122.13% for Q2 2025, and 188.06% during Q1 2025.